Niagen Bioscience Inc (NASDAQ:NAGE) has a beta value of 2.16 and has seen 1.02 million shares traded in the last trading session. The company, currently valued at $872.77M, closed the last trade at $11.08 per share which meant it lost -$0.18 on the day or -1.60% during that session. The NAGE stock price is -32.58% off its 52-week high price of $14.69 and 77.17% above the 52-week low of $2.53. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.11 million shares traded. The 3-month trading volume is 971.66K shares.
Niagen Bioscience Inc (NASDAQ:NAGE) trade information
Sporting -1.60% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the NAGE stock price touched $11.08 or saw a rise of 10.72%. Year-to-date, Niagen Bioscience Inc shares have moved 284.72%, while the 5-day performance has seen it change -7.44%. Over the past 30 days, the shares of Niagen Bioscience Inc (NASDAQ:NAGE) have changed -21.64%. Short interest in the company has seen 3.27 million shares shorted with days to cover at 3.35.
Niagen Bioscience Inc (NAGE) estimates and forecasts
The company’s shares have gained 110.25% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 23.87%.
4 analysts offering their estimates for the company have set an average revenue estimate of 28.36M for the current quarter. 4 have an estimated revenue figure of 30.71M for the next ending quarter. Year-ago sales stood 22.74M and 25.58M respectively for this quarter and the next, and analysts expect sales will grow by 24.70% for the current quarter and 23.87% for the next.
Earnings growth for 2025 is a modest 25.10% while over the next 5 years, the company’s earnings are expected to increase by 48.97%.
NAGE Dividends
Niagen Bioscience Inc is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Niagen Bioscience Inc (NASDAQ:NAGE)’s Major holders
Insiders own 34.44% of the company shares, while shares held by institutions stand at 33.09% with a share float percentage of 50.48%. Investors are also buoyed by the number of investors in a company, with Niagen Bioscience Inc having a total of 191.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 2.70% shares in the company for having 2.12 shares of worth $23.53 million while later fund manager owns 1.27 shares of worth $14.05 million as of May 31, 2025 , which makes it owner of about 1.61% of company’s outstanding stock.
